Articles by tag: pharma-market-analysis

Pediatric Dovato: ViiV application and geopolitics of the HIV market

ViiV has submitted applications to the FDA and EMA for dispersible Dovato tablets for children. We analyze the strategy, patents, and implications. Find out who will win.

Gedatolisib: Phase 3 success in PIK3CA-mutated cancer

Gedatolisib met the endpoint in the VIKTORIA-1 study, surpassing the standard of care. Learn how this will change the market. Read the detailed analysis.